Inspire Medical Systems, Inc. (INSP) PT Reduced to $64 as Truist Updates MedTech Outlook Ahead of Q1

TheFly reported connected April 15 that Truist Financial reduced its terms people for INSP from $70 to $64 portion maintaining a Hold stance connected the stock. The accommodation was made wrong a broader outlook connected MedTech up of first-quarter results, with expectations that show whitethorn conscionable oregon somewhat transcend cautious capitalist sentiment astir process volumes. However, the steadfast noted that the existent valuation discount versus peers appears warranted owed to near-term maturation uncertainty, peculiarly linked to slowing home enlargement and ongoing reimbursement-related challenges.

Similarly, a time earlier connected April 14, Royal Bank of Canada revised its outlook connected Inspire Medical Systems, Inc. (NYSE:INSP) and lowered its terms people from $68 to $56 portion maintaining a Sector Perform rating. This update besides came arsenic portion of a broader MedTech assemblage reappraisal up of first-quarter earnings. Despite acknowledging unchangeable underlying request conditions and mostly coagulated fundamentals with nary signs of large marketplace disruption, the steadfast highlighted that caller sentiment-driven weakness whitethorn beryllium overstated. At the aforesaid time, it pointed to operational pressures affecting utilization and caller halfway growth, including reimbursement coding challenges and delayed diligent progression related to GLP-1 therapy trends, which bounds near-term visibility crossed upcoming quarters.

In abstracted news, Inspire Medical Systems, Inc. (NYSE:INSP) volition study its Q1 2026 results connected May 4.

Inspire Medical Systems, Inc. (NYSE:INSP) is simply a aesculapian exertion institution based successful Minneapolis that develops implantable neurostimulation therapy for obstructive slumber apnea. It’s an FDA-approved instrumentality that stimulates the hypoglossal nervus arsenic an alternate to CPAP treatment.

While we admit the imaginable of INSP arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: Top 10 AI-Powered Biotech Stocks to Buy Right Now and 10 Most Undervalued Dow Stocks to Buy Now.

Disclosure: None. Follow Insider Monkey connected Google News.